Statement of the American Pharmacists Association
Before National Committee on Vital and Health Statistics
Subcommittee on Privacy & Confidentiality
Hearings on Privacy and Health Information Technology
March 31, 2005
Presented by Susan C. Winckler, RPh, JD
Members of the Subcommittee, thank you for inviting the American Pharmacists Association (APhA) to appear before you this morning. APhA welcomes the opportunity to present the views of the nations pharmacists on two important issues and their intersection: privacy and health information technology. I am Susan C. Winckler, a pharmacist and an attorney, and Vice President, Policy & Communications and Staff Counsel for APhA. APhAs more than 52,000 members include pharmacist practitioners, pharmaceutical scientists, student pharmacists, pharmacy technicians, and others interested in advancing the profession. Our members practice in virtually every health care setting where medications are used: community pharmacies, hospitals, long term care facilities, hospices, and many other environments.
Pharmacists are committed to protecting the privacy of individually identifiable health information, with specific responsibility for the patient health information gathered and used as an essential component of medication dispensing and medication therapy management. Pharmacists maintain and use individually identifiable information in patient records as an integral part of daily patient care and as important components of efforts to enhance quality and improve the safety of medication. The profession is concerned with protecting the privacy of the information they create, collect, and manage. My comments today will address the three core issues for your consideration: access, contribution, and integration. Each of these issues is important to assure that health information technology supports and improves patient care while protecting the privacy of patients information. In addition to this discussion, I have provided an excerpt of APhA policy relevant to todays discussion as an attachment to this statement.
Access
Pharmacists ability to access information as we expand health information
technology is essential. As the medication expert on the health care
team, our ability to care for patients would be improved with additional access
to relevant patient information, such as the results of blood cholesterol tests
to assess the effect of cholesterol-lowering interventions or medication blood
levels for therapies which require close monitoring. Access to
information within an electronic health record or shared using health
information technology is essential to all health care professionals, including
pharmacists.
Necessary access is not, however, unlimited. We recognize that some information may not be relevant to the pharmacists work, as well as the potential for situations where patients request limits on which providers may access what information. Such limits, when they do not compromise the pharmacists responsibilities under the relevant state laws to assess the appropriateness of medication therapy and accurately dispense medication, should be respected.
Our support for access to information distinguishes that information which is necessary for patient care and that information necessary for payment of health care claims. While payors certainly require access to some information to document provision of services and protect against fraud and abuse, payor access to information should be limited to a subset of the information necessary to provide patient care. Unfortunately, the implementation of the Health Insurance Portability and Accountability Act requirements around the minimum necessary issue do not appear to have resolved some of these questions about the scope of information available to payors.
And with any discussion of health information technology, patient information must be protected from unauthorized access from those outside of the health care community.
Contribution
Pharmacists ability to contribute to the patients health record is
also important. In addition to providing core information regarding the
use of medications, pharmacists are increasingly involved in helping
patients assess the progress of their therapy. Documenting this
information in the health care record provides essential information to
improving medication use, and is valuable to other health care professionals
working with that patient. In some situations, knowing why a
patient stopped using a certain medication may be just as important as knowing
that another patient continues to take a prescribed therapy. Such
information exchangein an environment that continues to protect patient
privacy--is only possible with appropriately structured health information
technology
Integration
Achieving a health information technology future that supports health care
professionals and patients ability to both access and contribute to
relevant health information is impossible without integrating the many existing
disparate systems. Whether the challenges emerge from differences created
as patients move from a hospital to a long term care facility or return to the
community environment, a fundamental barrier to efficient, effective health
information technology is the lack of standardization of information technology
systems across health care providers. A well-constructed system in a
hospital is useless to the community pharmacist if the structure and
architecture of the system operates on different standards. As health
information technology evolves, we must consider and address all of the
environments where health care is deliveredincluding community health
centers, community pharmacies, etc. Integration of all of these units is
essential, and can help in efforts to protect access to this information as
well.
And integration must extend beyond the integration of existing systems, or taking existing paper processes and translating them to an electronic format. If we merely move the existing health care communication system from paper to an electronic environment, we will have missed an opportunity to truly improve health care operations. Consider the prescription. The paper prescription of today looks much the same as it did 100 years agoproviding the patient name, drug name, quantity and directions. Moving this information electronically certainly addresses some potential for error and can introduce efficiencies, but its also likely that our need for information has increased in the last 100 years. Isnt it time for prescriptions to contain more informationsuch as the intended use of the therapyto help prescribers, pharmacists, and patients improve the likelihood that the medication will do what is intended, and nothing it shouldnt? The intended use is not the diagnosis per seit is the intended outcome for a designated medication, such as a medication prescribed for pain. Including such information helps the pharmacist tailor their communications with the patient, and the patient better manage their medications. As we look to the future of health information technology, we must consider potential improvements along with the transition of existing practices.
In conclusion, thank you for the opportunity to provide comments on this important issue. APhA appreciates the Subcommittees attention to this important debate. We offer our assistance to the Subcommittee as you continue your valuable work. Thank you.
Relevant Policy
1998 Access and Contribution to Health Records
(JAPhA 38(4): 417. July/August 1998)
1996 Confidentiality of Patient Data
APhA supports the establishment of uniform national privacy protection standards for personally identifiable health information. These standards should:
(JAPhA. NS36(6):396. June 1996)